Novel MicroRNA Reporter Uncovers Repression of Let-7 by GSK-3β

Rong Guo1, Kotb Abdelmohsen, Patrice J Morin

  • 1Laboratory of Genetics, National Institute on Aging-Intramural Research Program, NIH, Baltimore, Maryland, United States of America.

Plos One
|July 11, 2013
PubMed

Insights

Glycogen synthase kinase 3 beta (GSK-3β) inhibition increases let-7 microRNA levels, a tumor suppressor, in ovarian cancer cells. This suggests GSK-3β is a potential therapeutic target for ovarian tumorigenesis.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • let-7 microRNAs function as tumor suppressors by downregulating oncogenic proteins.
  • Reduced let-7 levels are observed in various cancers, including ovarian cancer.
  • A sensitive assay is needed to systematically measure cellular let-7 levels.

Purpose of the Study:

  • To develop and validate a novel let-7 reporter assay system.
  • To identify pathways regulating let-7 levels in ovarian cancer cells.
  • To evaluate glycogen synthase kinase 3 beta (GSK-3β) as a therapeutic target.

Main Methods:

  • Developed a pmirGLO-let7 reporter construct expressing chimeric mRNA with luciferase and let-7 binding sites.
  • Transfected ovarian cancer cell lines (BG-1, UCI-101) with the reporter system.
  • Screened kinase inhibitors and utilized RNA interference to identify regulators of let-7 activity.

Main Results:

  • The pmirGLO-let7 assay showed inverse correlation between luciferase activity and let-7 levels.
  • Inhibition or silencing of GSK-3β significantly increased both mature and primary let-7 levels in ovarian cancer cells.
  • GSK-3β inhibition led to decreased cell survival and implicated p53 in the regulation of let-7 biosynthesis.

Conclusions:

  • GSK-3β plays a critical role in repressing let-7 biosynthesis in ovarian cancer.
  • Targeting GSK-3β represents a promising therapeutic strategy for ovarian tumorigenesis.
  • The pmirGLO-let7 assay is a valuable tool for studying let-7 regulation.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...